ParcelBio
YC W24 · Active · Elevated mRNA for transformative medicines.
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YCS21 | |
| Other | Active | YCW24 | |
| Other | Acquired | YCW22 | |
| Other | Active | YCW24 | |
| Other | Active | YCS22 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Active | YCS20 | |
| Other | Active | YCW22 | |
| Other | Inactive | YCS18 | |
| Other | Active | YCW21 | |
| Other | Active | YCW24 |
Also from W24
All of W24About ParcelBio
ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform uses novel RNA domains to enhance protein expression and extend activity, enabling therapies that reach the thresholds required for meaningful, and potentially curative, clinical outcomes. The company is advancing programs in autoimmune disease, oncology, and encoded protein therapeutics.
- YC batch
- W24 · Winter 2024
- Status, per YC
- Active
- Category
- Other
- Team size
- 6
- Location
- San Francisco, CA, USA
- Checked
- 32m ago
YC tags: Gene Therapy, Synthetic Biology, Biotech, Therapeutics, Drug discovery
ParcelBio: questions
Which YC batch was ParcelBio in?
ParcelBio was in Y Combinator's Winter 2024 batch (W24).
Is ParcelBio still active?
Y Combinator lists ParcelBio as active.
Where is ParcelBio based?
ParcelBio lists San Francisco, CA, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.